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Synthesis ofnitrogen oxides is a newly discovered biochemical process in mammals
(1) carried out by activated macrophages (2) and endothelial cells (3, 4). In both
cell types, these oxides derive from the guanido nitrogens of L-arginine (5-7), but
there are marked differences in the agents inducing their synthesis and in the ki-
netics of their release (8-10). In macrophages, the known products of this class are
nitrite (N02- )' and nitrate (N03 - ) (2, 8). Production of N02_/NO3- by macro-
phages is associated with L-arginine-dependent cytostasis of tumor cells (6) and cryp-
tococcus (11). However, N02_/NO3_ themselves lack cytostatic activity (12), sug-
gesting the involvement of a more reactive compound that may be intermediate in
the reaction sequence between arginine and N02 - /N03-. Endothelial cells produce
nitric oxide (NO-), a highly reactive compound recently identified as a major
endothelium-derived relaxing factor (EDRF) (3, 4, 10). EDRF elicits an elevation
in cGMP in vascular smooth muscle cells and platelets, leading to vasodilatation
(13) and inhibition of platelet aggregation and adhesion (14). We show here that
activated mouse macrophages release a molecule derived from the guanido nitrogens
of L-arginine, which has both EDRF bioactivity and NO .-like chemical reactivity
toward heme-containing and Fe-S proteins.
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Materials and Methods
Tissue Preparation and Cell Culture.
￿
Rabbits (New Zealand White) were anesthetized with
pentobarbital sodium (30 mg/kg) and killed by a blow to the skull. Thoracic aorta was quickly
excised, cut into 3-5-mm rings, de-endothelialized, and attached to a transducer (RT03;
Grass Instruments, Quincy, MA) for recording of isometric tension with a Model 7 Poly-
graph (Grass Instruments). Rings were maintained under 2 g of resting tension and super-
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fused with Krebs-Henseleit solution (KHS) (pH 7 .4, 27°C) saturated with 95% 02/5% C02
at a flow rate of 6.4 ml/min. Tissues were equilibrated for 60 min before contraction with
norepinephrine (NE) (10 ttM). To avoid oxidation, ascorbic acid (54 UM) was present in the
NE-containing perfusion medium. The absence of endothelium was demonstrated by lack
of relaxation in response to 10 PM acetylcholine.
Macrophages (M0) were obtained from C3H/HeJ mice (The Jackson Laboratories, Bar
Harbor, ME) after intraperitoneal injection of thioglycollate broth 4 d previously, or were
the mouse M0-like tumor cell line RAW 264 (American Type Culture Collection, Bethesda,
MD) (15). Mo beads were prepared by allowing M0 (9 x 10' for C3H/HeJ, 1.9-3.4 x 10'
for RAW 264) to adhere in tissue culture flasks to 2.1 ml (packed volume) of Cytodex 3 beads
(PharmaciaFine Chemicals, Piscataway, NJ) for 12-24 h in 35 ml ofMinimum Eagle's Medium,
a modification, containing 8% calf serum (Hyclone Systems, Logan, UT) at 37 °C in 5%
C02. M0 on beads were activated by exposure to rIFN-y (500 U/ml, murine; Genentech,
Inc., South San Francisco, CA) for 12-16 h followed by addition of bacterial LPS (5 t~g/ml;
Escherichia coli 0111 :114, List Biological, Campbell, CA) 5-10 h prior to the experiment. For
measurements of N02 - /N03- synthesis, aliquots of the cells on beads were removed from
the stock cultures and their subsequent N02- /N03- synthesis was measured over 6-12 h as
described previously (2) . After loading into the columns, the M0-bearing beadswere washed
with two column volumes of KHS before use. After each experiment, the number of macro-
phages remaining in the columns was determined by lysing the cells and fixing the nuclei
for counting in a hemocytometer as described (16).
Spectrophotometric Assayfor NO. and Nitrogen Dioxide (NO2).
￿
Ferredoxin (Fd) from Clostridium
pasteurianum was dissolved under N2 in deoxygenated PBS (pH 7 .2) to form an 11.3-AM Fd
solution (E390 = 24 mM/cm; reference 17) . This solution (900 P,1, 10.2 nmol) was transferred
anaerobically to an N2-flushed anaerobic cuvette. Authentic NO . (Matheson Gas Products,
Inc., Rutherford, NJ) that had passed through 1 M KOH was transferred with a gas-tight
syringe in sequential 10-141 amounts to the cuvette. After each addition, the cuvette was mixed
by several inversions and the spectrum was recorded from 600 to 350 nm in a spectrophotom-
eter (model 557 ; Hitachi Inc., New York, NY). Reactions of N02 were carried out as with
NO . except N02 was not passed through 1 M KOH. After addition of 70 ILI NO- (2 .87 P,mol)
or 30 Al of N02 (3.41 14mol), each solution was aerated, the pH was recorded, and N02- /
N03- concentrations were measured. The results for NO- were pH = 6.01 t .08, N02- +
N03- = 3 .01 f .17 mM (% N02- = 101 ± 4%) . In contrast to the mild acidification
caused by NO., addition of 30 Al N02 reduced the pH to 4.05 f 1.47, sometimes precipi-
tating the Fd. The concentration of N02- + N03- after addition of 30 JAI N02 was 3 .29 ±
.71 mM (% N02- = 61 ± 26%). For the reaction of N02- with Fd (n = 3), a 400-mM
stock solution of NaN02 was used and the Fd was dissolved in PBS buffered to pH 5.9 with
20 mM morpholinoethane sulfonate to control for the acidification that occurred in the NO-/Fd
reaction.
N02- and N03- Assay.
￿
N02- and N03- were measured by an automated colorimetric
assay based on the Griess reaction described in detail elsewhere (2). Briefly, samples were
reacted with the Griess reagent (1olo sulfanilamide, 0.1% naphthylethylene diamine dihydro-
chloride, 2.5% H3PO4) and the N02- concentration was determined by monitoring at 543
nm. N03- in the sample was measured after reduction of N03- to N02_ . Data were ex-
pressed either in concentration units or as nmoles produced over the indicated time periods.
The percentage of N02- in the sample relative to the total N02- plus N03- was also de-
termined.
Other Reagents.
￿
N°,O-dimethyl-L-arginine (DMA) was from Chemical Dynamics Corp.,
South Plainfield, NJ . All other chemicals were from Sigma Chemical Co., St. Louis, MO.
Results
Bioassayfor NO. .
￿
The bioassay for Mo-derived NO- was based on that for EDRF
(3, 4, 10). A ring of rabbit thoracic aorta was denuded of endothelial cells and super-
fused with the admixture of two streams of KHS, one containing 10 14M NE and
the other exiting one oftwo columns: an empty control column, or an experimentalSTUEHR ET AL.
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column containing Cytodexbeads to which C3H/Hejmouseperitoneal M0 or RAW
264 mouse M0-like tumor cells had adhered. The M0 were activated for
N02-/N03- production, either by prior exposure to rIFN-y and LPS (8), or to a
lesser degree, by exposure to the Cytodexbeadsthemselves. The M0 perfusateelicited
a relaxation of the precontracted arterial ring in six of six experiments. Addition
of0.5 MM L-arginine to the solution perfusingthe M0 column augmented thevaso-
relaxation. The degree of augmentation by L-arginine was inversely proportional
to theextent ofrelaxation inducedby theM0 perfusate without addition of L-arginine
(Fig. 1).
Ferrous hemeproteins reactwith NO. with high affinity (18), andblockvasorelax-
ation mediated by NO. (19). Similarly, perfusion of the M0 column with ferrous
myoglobin (either reduced by ascorbate [Fig. 1, A and B], or freshly prepared under
nonoxidizing conditions [Fig. 1 C] completely blocked vasorelaxation. The inhibi-
tion specifically required hemeprotein, because ascorbate alone did not reverse the
M0-induced relaxation (not shown). Inhibition of vasorelaxation by myoglobin/as-
corbate was not due to toxicity to the M0, because removal of myoglobin/ascorbate
from the perfusion buffer led to immediate restoration of M0-mediated relaxation
in all cases. L-arginine and myoglobin/ascorbate did not act directly on the arterial
ring, because L-arginine and myoglobin/ascorbate caused neither contraction nor
relaxation when perfused through an empty column directly onto thering (Fig. 1 B).
The vasorelaxing factor released from the M0 was short lived. As shown in Fig. 1,
A and B, collected column effluent had no vasorelaxing effect when it was passed
over the aortic ring a second time. Indomethacin had no effect on M0-mediated
vasorelaxation (Fig. 1 C), militating against a role for cyclooxygenase metabolites
(10). However, vasorelaxation was reversed 50% upon addition of 10',M methylene
blue (Fig. 1 B), an inhibitor of guanylate cyclase in vascular smooth muscle (19),
suggesting that the M0-derived vasorelaxant, like NO., acts through activation of
this enzyme (4, 13).
N°-methylated arginine analogs serve as competitive inhibitors of synthesis of
N02_/NO3_ in M0 (6, 20) and NO. in endothelial cells (21, 22). Perfusion of 0.13
mM N°N~-dimethyl-L-arginine (DMA) through the RAW 264 M0 column com-
pletely blocked production of the relaxing factor (Fig. 1 D) . Addition of 2.5 mM
L-arginine to the perfusion medium containing DMA reversed the inhibition and
potentiated the production of the M0-derived relaxing factor. Similar results were
seen with C3H/He M0 using the related inhibitor N~-monomethylarginine (not
shown). This indicated that generation of the relaxing factor was closely associated
with M0 metabolism of L-arginine to N02-/N03 -. However, authentic NaN02 re-
laxed arterial rings only at concentrations above 50,uM; 50% relaxation required
2.5 mM N02- (n = 3, not shown). Although the M0 used in these experiments
were actively synthesizing N02- (see Fig. 1, legend), the N02- concentration in
theeffluent ofM0 columns that relaxed the aortic ring wasonly 1.8 /AM(n = 3, Fig. 1
C). Thus, N02- itself was not responsible for the vasorelaxation.
In sum, production ofthe M0-derived vasorelaxant was augmented by L-arginine
and inhibited by arginine analogs methylated on a guanido nitrogen. N02- was
not the active principle. The vasorelaxant was scavenged by ferrous myoglobin. It
was highly labile in an aerated aqueous solution at pH 7.4. Its actions were blocked
by methyleneblue but not indomethacin. These are hallmarksof NO . (3, 4, 7, 19, 21).A
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FIGURE 1.
￿
Representative tracings demonstrating the secretion of a vasorelaxing factor by acti-
vatedprimary Mo (n = 3) or by theM0 cell line RAW264(n = 5). Rings of rabbit aortawere
denudedof endothelium and superfused with KHS. Thesuperfusion medium was formed from
twostreams (eachflowingat 3.2 ml/min)mixedjust abovethe aortic ring. One stream contained
thevasoconstrictorNE, whiletheother stream came from oneoftwo columns: an emptycontrol
column, or an experimental column containing M0 adherent to Cytodex beads. (A and B) A
single aortic ring was superfused with the effluent from columns containing control (A) or acti-
vated (B) C3H/HeJ Mo (1.1-1.3 ml bed volume; 1.7 x 107 Mo/column). (C and D) The aortic
ring was superfused by a column containing activated Mo-like RAW 264 tumor cells (1.2 and
1.3 ml bed volume; 1.8 and 0.9 x 107 MoJ/column). M0 were activated (M0*) forN02-/N03-
synthesis by priorexposure to rIFN-,y andLPS. (A-D)Mo generatedN02- at 0.80 t 0.16, 1.34
t 0.48, 1.62 t 0.17, and 0.98 t .14 nmol/h per 106 cells, respectively (mean t SD, n = 3).
Thus, control Mo were activated for N02-/N03_ synthesis to some extent by cultivation on
Cytodex beads alone. Arrows indicate the onset of superfusion with the M0 column effluent or
drugs. Mor* effluents (B and C) relaxed the aortic ring in the presence of NE, whereas control
Mo effluents (A) hadlittle relaxant effect; L-arginine (L-arg; 0.5 mM) potentiated the relaxation
in both cases. M0- and Mot-induced relaxation was reversed by reduced myoglobin (Myo; 125
Wg/ml) or Myo + ascorbate (Asc; 0.5 mM) andblocked by methyleneblue (MB; 10 /AM), but
not by indomethacin (Indo; 10 pM). DMAcompletely antagonized the Mo-induced relaxation
in the absence of L-arginine; but with addition of L-arginine, production of the M0-derived
relaxingfactor wasfullyrestored andeven potentiated compared with that produced before addi-
tion of DMA or L-arginine (D). (A-C) An interval is indicated during which the M0 column
effluent causing vasorelaxation was collected after its passage over the aortic ring (COLLECT
EFFLUENT). Reperfusion of the ring with this collected effluent 10 min later (PERFUSE EF-
FLUENT) did not elicit a second vasorelaxant effect. The N02- concentration in the effluent
collected in C was 1.8 pM and in KHS alone was 1.3 WM (n - 3).STUEHR ET AL .
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Spectrophotometric Assayfor N0 . andN02 .
￿
Next, we wished to find a molecule that
would react with Mo-derived NO . under aerobic tissue culture conditions and thus
serve as an independent assay ofNO- production . The cultures had to be aerobic
to permit Mo generation ofnitrogen oxides. Trapping NO . was necessary, because
in aerated solutions, NO . reacts rapidly with 02 to form nitrogen dioxide (N02),
which in turn reacts with water to yield NO2- and N03-. Thus, ifNO . is produced
by M0, it will not accumulate .
Mass spectroscopy has been used to measure NO- in endothelial cell perfusates
after their collection into a solution of refluxing potassium iodide/acetic acid (7).
However, this method does not discriminate between NO . released by endothelial
FIGURE 2 .
￿
Spectroscopic assay ofreaction ofclostridial ferredoxin (Fd) with three oxides ofnitrogen .
(Mainfigure) Fd was dissolved under N2 in deoxygenated PBS (pH 7.2) to form an 11.3-/4M Fd
solution, of which 900,u1 (10 .2 nmol) was transferred anaerobically to an N2-flushed anaerobic
cuvette. Authentic NO . that had passed through 1 MKOH was transferred with a gas-tight sy-
ringe in sequential 10 Wl amounts to the cuvette . After each addition, the cuvette was mixed by
several inversions and the spectrum recorded from 600 to 350 nm. The figure represents one
of four similar experiments . (Upper inset) Spectrum of Fd before (A)and after (B) reaction with
70 Al (2.87 Wmol) NO ., showing lack of change in the UV. Spectrum of buffer control is also
shown (C) . (Lower inset) Bleaching of Fd chromophore at 410 nm as a function of added NO .
(O), N02 (A), or NO2- (p). Reactions of NO- (n = 4) and N02 (n = 3) gas were carried out
as above; reaction ofN02- with Fd (n = 3) was done in PBS buffered to pH 5.9 as described
in Materials and Methods .1016
￿
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Mo-mediated loss of Fd
absorbance at 410 nm (A, B) and
production of N02-/N03- (C, D) as
afunction of time (A, C) and number
ofMo (B, D). (A and C) RAW264Mo
were plated at 1.2 x 106/well and ac-
tivatedfor6hwith rlFNyand LPS as
described in Fig. 1. The monolayers
were then washed once with 1 ml of
Dulbecco's minimum Eagle'smedium
with 8% calfserumbutwithout phenol
redor L-arginine (DMEM-ARG). This
wasaspirated andreplacedwith0.7 ml
DMEM-ARG containing Fd (8.2 pM).
Thefollowingwerethen addedin 3-5-pl
quantities to give the final concentra-
tions indicated: nothing(*); L-argi-
nine (1 mM) (0); N02- (230 uM)
(O); L-arginine (1 mM) plus catalase
350 U/ml) (0). The wells were incu-
bated at 37'C under 5% C02 for the
times indicated and the A4to of the
conditioned medium compared with
identically cultured cell-free control
media containing Fd or Fd plus cata-
lase. The concentration of N02-/
N03-wasalso determined foreach so-
lution andcorrected forthevalueofthe
0
￿
3
￿
8
￿
9
￿
0.0 0.4 0.8 1 .2
￿
cell-free control medium containing
time (h)
￿
cells x 106
￿
catalase (N02-/N03 - ￿= 14.5 AM).
(B andD). Theexperiments were per-
formed as above, varying thecell num-
berandcollecting the supernatants at
9h. Thefigure showsoneoffive similar
experiments, each in triplicate.
cells and NO- arising in the collection vessel via reduction of N02- . Hemeproteins
have been used to trap NO- (4, 23). Preliminary experiments revealed that although
nitrosyl-hemecomplexes were stable in an anaerobic atmosphere, they decomposed
rapidly in aeratedculturemedium (not shown). In view of these drawbacks, we turned
to Fe-S proteins. NO , reacts irreversibly with some Fe-S proteins (24), decreasing
their absorbance in the visible spectrum. Thus, bleaching of Fe-S chromophores
could serve as acumulative measure of NO- release. Indeed, authentic NO- caused
concentration-dependent bleachingof the visible spectrum of clostridial ferredoxin
(Fd), an 8-iron, 8-sulphur Fe-S protein (Fig. 2). The absorbance of Fd at 410 de-
creased in a linear fashion with increasing amounts of NO- up to 2 /Amol (Fig. 2,
lower inset). The absorbance of Fd in the ultraviolet was unchanged under the same
conditions (upper inset), demonstrating that the decrease in absorbance in the visible
region was not due to dilution of thechromophore, and suggesting that the reaction
of NO. with Fd was relatively specific for the Fe-S clusters. Authentic N02 also
bleached Fd (lower inset). In this case, acidification caused by hydration of N02 com-
plicated interpretation of the dose curve above 2 p.mol N02. In contrast, N02- did
not bleach Fd, even at pH 5.9 (lower inset). Finally, the spectrum of Fd was stable
over at least 19 h in tissue culture medium at 37°C.
Thus, we used bleaching of Fd to test for NO./NO2 production by activated M0
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in culture (Fig. 3). Mo bleached Fd; the magnitude of bleachingwas proportional
to time, cell number, and the concomitant production of N02_ - Only a minor
amount of Fd bleachingoccurred in M0 cultures in which synthesis ofnitrogen oxides
was blocked by omitting L-arginine, even when exogenous NaN02 was added at the
start of the coincubation with Fd. Thus, the only Mo product(s) required for sub-
stantial bleaching appeared to be those distal to L-arginine and proximal to N02-
in the biosynthetic pathway of nitrogen oxides. Hypohalous acids can also bleach
Fd (25), but were not involved in this case, because production of H202, the
precursorofhypohalous acids, is not dependenton L-arginine (26), and in anyevent
the addition of catalase to break down H202 had no effect on Mo bleaching of Fd.
Unfortunately, control Mo (those not producing N02_/NO3_) could not be tested
in this system, because Fd itself partially activated the cells for N02_/NO3_ syn-
thesis (not shown).
Discussion
The combined evidence from the biological and biochemical assays described above
strongly suggests that activated Mo release an L-arginine-derived compound that
is either NO. or a closely related substance with similar reactivity, such as N02.
Compared with agonist-triggered endothelial cells (3, 4, 10), activated Mo secrete
the NO--like compound over much longer periods, and the total amount produced
per cell may be far greater. The factors inducing NO . release require more study,
but are probably similar to those inducing secretion of N02-/NO3- . Inducers of
N02_/NO3_ include LPS and IFN-y, or synergistic combinations of IFN-'Y with
TNF, or LPS with IFN-a or IFN-a (8, 9).
Although Mo release of the NO--like compound was augmented by exogenous
L-arginine and completely blocked by DMA, variable amounts were still released
by Mo in the absence of exogenous L-arginine (Fig. 1). This suggests existence of
sources of L-arginine within the Mo. Such sources are probably short lived, since
this metabolic pathway exhibits a strict requirement for exogenous L-arginine when
measured over longer time periods (5).
These findings prompt a number of speculations about the role of NO. secretion
in the physiology of Mo. First, NO . may be a specific mediator of arginine-dependent
antitumor and antimicrobial effects of Mo, including inactivation of the target
cell Fe-S enzymes cis-aconitase (27), succinate:ubiquinone oxidoreductase, and
NADH:ubiquinone oxidoreductase (28). Second, Mo may play a previously un-
suspected part in regulating smooth muscle tone during inflammatory or immune
responses. Interest in this hypothesis is heightened by the abundance of Mob in the
renaljuxtaglomerular apparatusand interstitium (29), gastrointestinal mucosa (30),
bronchial epithelium (31), pulmonaryvasculature, interstitium, andalveoli (31), and
sinusoids of liver, spleen, and marrow, as well as in wounds, granulomas, and athe-
romas. Forexample, themononuclear phagocytes associated with bloodvessels may
affect systemic blood pressure during sepsis, or regional blood flow in inflammation
and wound healing. Third, secretion of NO. by vessel-associated M0 or monocytes
couldinfluencenot only smooth muscle cellsand platelets but also endothelial cells.
Fourth, in lymphocytes, activation of guanylate cyclase or inactivation of certain
Fe-S enzymes by NO . might contribute to Mo-mediated stimulation or suppres-
sion of immune responses.1018
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Summary
L-arginine-dependent synthesis of nitrite (N02- ) and nitrate (N03- ) by macro-
phages correlates with and is required for their execution of nonspecific cytotoxicity
toward some tumor cells and microbes. However, the bioactive L-arginine metabo-
lites responsible for cytotoxicity are unknown. Mammalian endothelial cells have
recently been shown to release nitric oxide (NO.); we therefore determined if this
reactive metabolite was synthesized by activated murine macrophages. Macrophage-
derived NO. was detected by two independent methods: a bioassay for NO .-mediated
relaxation ofpreconstricted rings of rabbit aorta; and a spectroscopic measurement
of the reaction of NO . with clostridial ferredoxin, an Fe-S protein. After activation
with IFN-'Y and LPS, macrophages continuously secreted a substance that relaxed
rabbit aortic rings denuded ofendothelium. Production of the vasorelaxant was en-
hanced by 0 .5 MM L-arginine and inhibited reversibly by 0-methylated L-arginine
analogs that block macrophage N02_/NO3_ synthesis. The vasorelaxant was
scavenged by ferrous myoglobin, was labile, and was neither N02- nor a cycloox-
ygenase metabolite. Activated M0 also secreted a substance that bleached Fd, a reac-
tion carried out by NO . and N02, but not N02". Macrophage bleaching of Fd cor-
related directly with time, cell number, and concomitant N02 - /N03- production,
required L-arginine, and was independent of reactive oxygen intermediates. Thus,
activated murine M0 release NO . and/or a closely related, highly reactive nitrogen
oxide such as N02, during their conversion of L-arginine to N02- /NO3". NO . and
N02 may mediate L-arginine-dependent pathologic effects of M0, as well as physio-
logic effects not previously considered for this widely distributed cell type.
We thank Drs. Jack Peisach and Ralph Nachman for helpful discussions, and Claudia Morris
for expert assistance.
Receivedfor publication 17 October 1988 and in revised form 21 November 1988.
References
1 . Green, L. C., K. de Luzuriaga, D. A. Wanger, W. Rand, N. Istfan, V. R. Young, and
S. R. Tannenbaum. 1981 . Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. USA. 78:7764.
2. Stuehr, D. J ., and M. A. Marietta. 1985. Mammalian nitrate biosynthesis: mouse mac-
rophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide.
Proc. Natl. Acad Sci. USA. 82:7738.
3. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts
for the biological activity ofendothelium-derived relaxing factor. Nature (Loud.). 327:524.
4. Ignarro, L. J., G. M . Buga, K. S. Wood, R. E. Byrns, and G. Chaudhuri. 1987.
Endothelium-derived relaxing factor produced and released from artery and vein is ni-
tric oxide. Proc. Natl. Acad Sci. USA. 84:9265.
5. Iyengar, R., D. J. Stuehr, and M. A. Marietta. 1987. Macrophage synthesis of nitrite,
nitrate and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl. Acad.
Sci. USA. 84:6369.
6. Hibbs, J. B., Jr., R. R. Taintor, and Z. Vavrin. 1987 . Macrophage cytotoxicity: role for
L-arginine deiminase and imino nitrogen oxidation to nitrite. Science(Wash. DC). 235:473 .
7. Palmer, R. M. J., D. S. Ashton, and S. Moncada. 1988. Vascular-endothelial cells syn-
thesize nitric oxide from L-arginine. Nature (Lond). 333:664.STUEHR ET AL.
￿
1019
8. Stuehr, D. J., and M . A. Marietta. 1987. Induction of nitrite/nitrate synthesis in murine
macrophages by BCG infection, lymphokines, or interferon-.y. J Immunol. 139:518.
9 . Ding, A., C. F Nathan, and D. J. Stuehr. 1988. Release ofreactive nitrogen intermediates
and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of
activating cytokines and evidence for independent production. J Immunol. 141:2407 .
10 . Furchgott, R. F 1984. The role ofendothelium in the responses ofvascular smooth muscle
to drugs. Annu. Rev. Pharmacol. Toxicol. 24:175.
11 . Granger, D. L., J. B. Hibbs, Jr, J. R. Perfect, and D. T. Durack. 1988. Specific amino
acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.
J Clin. Invest. 81:1129.
12 . Stuehr, D. J., C. Morris, and C. F. Nathan. 1988. Cytostasis from nitrite, a product
of activated macrophages. FASEB (Fed. Am. Soc. Exp. BioL)J . 2 :A1452.
13 . Murad, F 1986. Cyclic guanosine monophosphate as a mediator ofvasodilation. J Clin.
Invest. 78:1.
14. Azuma, H., M. Ishikawa, and S. Sekizaki. 1986. Endothelium-dependent inhibition of
platelet aggregation. J Pharmacol. 88:411.
15 . Stuehr, D. J., and M. A. Marietta. 1987 . Synthesis of nitrite and nitrate in murine mac-
rophage cell lines. Cancer Res. 47 :5590.
16. Nakagawara, A., and C. F Nathan. 1983. A simple method for counting adherent cells:
application to cultured human monocytes, macrophages, and multinucleated giant cells.
J. Immunol. Methods. 56:261.
17. OrmeJohnson, W. H., and H. Beinert. 1969. Heterogeneity of paramagnetic species
in two iron-sulfur proteins: Clostridium pasteurianum ferredoxin and milk xanthine oxi-
dase. Biochem. Biophys. Res. Commun. 36:337.
18. Yonetani, T., H. Yamamoto, J . E. Erman, J. S. Leigh, Jr., and G. H. Reed. 1972. Electro-
magnetic properties of hemoproteins. J. Biol. Chem. 247:2447.
19. Martin, W, G. M. Villani, D. Jothianandan, and R. F Furchgott. 1985. Selective blockade
of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and
by methylene blue in the rabbit aorta. Pharmacol. Exp. Ther. 232 :708.
20. Hibbs, J. B., Jr., Z. Vavrin, and R. R. Taintor. 1987 . L-arginine is required for expres-
sion of the activated macrophage effector mechanism causing selective metabolic inhibi-
tion in target cells. J Immunol. 138:550.
21 . Palmer, R. M. J., D. D. Rees, D. S. Ashton, and S. Moncada. 1988. L-arginine is the
physiological precursor for the formation of nitric oxide in endothelium-dependent relax-
ation. Biochem. Biophys. Res. Commun. 153:1251 .
22 . Sakuma, I., D. J . Stuehr, S. S. Gross, C. Nathan, and R. Levi. 1988. Identification of
arginine as a precursor ofendothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA.
85:8664.
23 . Goretski, J ., and T C. Hollocher. 1988. Trapping of nitric oxide produced during
denitrification by extracellular hemoglobin. J Biol. Chem. 263:2316.
24. Salerno, J. C ., and T Ohnishi. 1976. Tetranuclear and binuclear iron-sulfur clusters in
succinate dehydrogenase: a method of iron quantitation by formation of paramagnetic
complexes. Biochem. Biophys. Res. Commun. 73:833.
25 . Rosen, H., and S. J. Klebanoff. 1985. Oxidation of microbial iron-sulfur centers by the
myeloperoxidase-H202-halide antimicrobial system. Infect. Immun. 47:613.
26 . Tsunawaki, S., and C. F Nathan. 1984. Enzymatic basis of macrophage activation: ki-
netic analysis of superoxide production in lysates of resident and activated mouse perito-
neal macrophages and granulocytes. J Biol. Chem. 259:4305.
27. Drapier, J . C., and J. B. Hibbs, Jr. 1986. Murine cytotoxic activated macrophages in-
hibit aconitase in tumor cells. J Clin. Invest. 78:790.1020
￿
NITRIC OXIDE PRODUCTION BY MACROPHAGES
28 . Granger, D. L., and A. L. Lehninger. 1982 . Sites ofinhibition of mitochondrial electron
transport in macrophage-injured neoplastic cells. J. Cell. Biol. 95:527.
29 . Hume, D. A., and S. J. Gordon. 1983 . Mononuclear phagocyte system of the mouse
defined by immunohistochemical localization of antigen F4/80. f. Exp. Med. 157:1704.
30. Lee, S. H., P. Starkey, and S. Gordon. 1985. Quantitative analysis of total macrophage
content in adult mouse tissues. J. Exp. Med. 161 :475.
31 . Brain, J. D. 1988. Lung macrophages: how many kinds are there? What do they do?
Am. Rev. Resp. Dis. 137:507.